2021 CPIP-A Case 1: Transfusion Medicine – Testing and Transfusing Patients With Sickle Cell Disease - CPIP0101W.2021
Untitled Document


This activity will help pathologists understand issues surrounding pretransfusion testing, indications for transfusion, and complications of transfusion specific to the sickle cell population.

Credit Type: CME
Duration: 1 hour 15 minutes
Launch Date: January 18, 2021
Expiration Date: January 17, 2024 12:00 AM (ET)
Pricing: Junior Member Fee: $10.00
MOC Category: Medical Knowledge, Patient Care

Registration Information
THIS ACTIVITY REQUIRES CREDIT CARD PAYMENT. If you ordered this product in advance, click Learning Search to locate the activity.

To enroll in the series with one easy payment, or to enroll multiple participants from the same institution, call 800-323-4040 option 1. This option is only available until December 31, 2021, after this date this activity is only accessible by an online credit card payment.

Description
Patients with sickle cell disease often require chronic transfusion therapy throughout their lifetime. However, indications for transfusion are different for patients with sickle cell than the general population. Additionally, patients with sickle cell disease are at higher risk for alloimmunization. Because sickle cell disease is so common in the United States, pathologists should be prepared to assist in the care of these patients to reduce adverse effects of transfusion.

This clinical pathology activity is intended for pathologists.

Objectives
After completing this assessment activity, you should be able to:

  1. Recognize various clinical presentations of sickle cell disease (SCD) for which red blood cell transfusion is indicated.
  2. Advise clinicians concerning guidelines and goals for transfusion in SCD.
  3. Identify types of testing for red blood cell antigens in SCD.
  4. Explain how to manage acute complications of SCD using red blood cell exchange transfusion.
  5. Describe hyperhemolytic syndrome as a complication of red blood cell transfusion in SCD.

Related Link
Clinical Pathology Improvement Program

CME Information
Accreditation: The College of American Pathologists (CAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Category 1: The College of American Pathologists designates this internet enduring material educational activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Passing Requirements
You must answer the assessment questions and complete the evaluation to claim credit and print your certificate.

Payment Information
To pay with a check, print a copy of this page and send it with your check to the address below. You will be notified when your payment has been processed and you have been registered into the activity.

College of American Pathologists
Education Division
325 Waukegan Road
Northfield, IL 60093-2750

Refund Policy
Refunds will be handled on an exception basis. Please submit your request to the CAP in writing via email at education@cap.org or fax at 847-832-8006.

Technical Requirements
Pop-up blockers must be turned off.

CAP Learning has recognized that some Veteran’s Administration, US Government, and military participants may have difficulty accessing the online assessment portion of this activity. If you experience difficulty or have any questions, please contact a representative of the CAP Learning Division at 800-323-4040 option 1 or education@cap.org.

Availability
This activity and evaluation are available January 18, 2021, and expire January 17, 2024, at 12:00 AM (ET). You must claim credit by this date and time.

CC: CPIP0101W.2021






Non-Member Price:     
 
Member Price:    

2021 CPIP-A Case 1: Transfusion Medicine – Testing and Transfusing Patients With Sickle Cell Disease